论文部分内容阅读
反复呼吸道感染(RRI)是儿童时期常见病.近年来.国内对小儿反复呼吸道感染的防治作了较多的研究.并取得一些进展.本文结合有关文献,将临床上以西药为主的某些防治进展综述如下.1 多抗甲素是从甲型链球菌经发酵提炼而得的一种具有免疫活性的多糖类物质、是我国首创的一种新型免疫增强剂.它能提高外用血白细胞.激活网状内皮系统的吞噬功能,活化巨噬细胞及淋巴细胞,改善和增强机体的免疫功能.罗春华用多抗甲素治疗RRI 90例,收到较好效果.方法为多抗甲素片10mg/d,连续服3个月.结果:服药1个月、显效54例.好转28例.有效率91.1%.服药2个月IgA和IgG由服药前的869.9±432.2mg/L儿和9.25±2.54g/L增加到1099.2±395.2mg/L和10.88±2.54g/L.服药3个月显效74例,好转12例.有效率95.6%.15例停药后观察1～7个月,11例患上感1次.4例于停药后1～3月复发.
Repeated respiratory infections (RRI) is a common childhood disease.In recent years, the domestic prevention and treatment of recurrent respiratory tract infections in children made more research and made some progress.In this paper, the relevant literature, the clinical western medicine-based The progress of prevention and treatment are summarized as follows.1 Polystatin A is an immunosuppressive polysaccharide obtained from the fermentation of Streptococcus mutans A. It is a new type of immunostimulant initiated by our country and can increase the number of peripheral blood leukocytes Activation of the reticuloendothelial system phagocytosis, activation of macrophages and lymphocytes, to improve and enhance the body’s immune function. Luo Chunhua treatment of RRI 90 cases with poly-A, received good results. Methods for the multi-anti-A tablets 10mg / d, continuous service for 3 months.Results: 1 month medication, markedly effective in 54 cases improved in 28 cases with an effective rate of 91.1% .2 months medication IgA and IgG by the medication before 869.9 ± 432.2mg / L children and 9.25 ± 2.54g / L to 1099.2 ± 395.2mg / L and 10.88 ± 2.54g / L. After taking medicine for 3 months, 74 cases were improved, 12 cases improved.The effective rate was 95.6% .15 cases were observed after stopping for 1 to 7 months, 11 cases of a sense of the flu 1. 4 cases relapse after 1 to 3 months after stopping.